Blueprint Medicines Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Cash & Equivalents	-	237.39	171.95
Short-Term Investments	-	366.31	351.02
Cash & Short-Term Investments	603.7	603.7	522.97
Cash Growth	15.44%	15.44%	-
Receivables	-	228.06	271.47
Inventory	-	324.85	338.47
Other Current Assets	-	51.52	67.43
Total Current Assets	-	1,208	1,200
Property, Plant & Equipment	-	3,147	3,320
Other Intangible Assets	-	5.02	0.31
Other Long-Term Assets	-	56.66	72.51
Total Assets	-	4,417	4,593
Accounts Payable	-	197.99	223.34
Current Portion of Leases	-	3.44	2.4
Current Unearned Revenue	-	29.28	43.12
Other Current Liabilities	-	135.45	140.02
Total Current Liabilities	-	366.16	408.87
Long-Term Debt	-	35.18	70.06
Long-Term Leases	-	86.92	90.36
Long-Term Deferred Tax Liabilities	-	397.32	401.99
Other Long-Term Liabilities	-	38.98	32.34
Total Liabilities	-	924.56	1,004
Common Stock	-	57.47	57.47
Comprehensive Income & Other	-	3,435	3,532
Shareholders' Equity	3,493	3,493	3,590
Total Liabilities & Equity	-	4,417	4,593
Total Debt	125.54	125.54	162.81
Net Cash (Debt)	478.17	478.17	360.16
Net Cash Growth	32.76%	32.76%	-
Net Cash Per Share	83.23	83.23	62.68
Filing Date Shares Outstanding	5.74	5.75	5.74
Total Common Shares Outstanding	5.74	5.75	5.74
Working Capital	-	841.98	791.47
Book Value Per Share	607.57	607.57	625.19
Tangible Book Value	3,488	3,488	3,589
Tangible Book Value Per Share	606.70	606.70	625.14

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.